CONMED Corporation (NYSE:CNMD) Q2 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to CONMED’s Second Quarter Fiscal 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Conmed Corp (CNMD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 51,779,000 | $46,375,307 | +20% | 0.02% | |
| 2. | Deerfield Management James E. Flynn | 631,264 | $43,759,220 | +87% | 0.72% |
| 3. | 45,000,000 | $40,398,300 | +5% | 1.29% | |
| 4. | Millennium Management Israel Englander | 547,602 | $37,959,771 | +33% | 0.01% |
| 5. | 29,402,000 | $26,352,613 | -16% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $72.09 | 1,350 | Director | 16,460 | 2024-05-13 | Filing | |
| $69.26 | 1,442 | Director | 1,442 | 2024-05-08 | Filing | |
| $70.98 | 2,000 | Director | 2,000 | 2024-05-06 | Filing | |
| $68.30 | 3,000 | Officer | 10,807 | 2024-04-30 | Filing | |
| $94.63 | 2,000 | Director | 16,035 | 2020-03-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $71.82 | 4,000 | Officer | 63 | 2024-06-14 | Filing | |
| $109.93 | 2,300 | Officer | 63 | 2023-12-04 | Filing | |
| $102.40 | 1,200 | Officer | 63 | 2023-11-07 | Filing | |
| $107.31 | 2,000 | Officer | 63 | 2023-09-13 | Filing | |
| $112.00 | 1,355 | Officer | 0 | 2023-08-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,031,016 | $550,946,574 | 0.01% | |
| 2. | 3,420,011 | $374,525,405 | 0% | |
| 3. | 2,757,108 | $301,930,897 | 0.07% | |
| 4. | 2,345,697 | $256,877,278 | 1.28% | |
| 5. | 1,187,053 | $130,213,498 | 0% |
News See All
Should You Expect CONMED (CNMD) to Grow Above Average and Expand its Margin?
ClearBridge Investments, an investment management company, released its “ClearBridge SMID Cap Growth Strategy” first quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Worst-Performing Stocks Insiders are Buying in 2024
In this article, we will take a detailed look at the 10 Worst-Performing Stocks Insiders are Buying in 2024. If you want to skip our detailed analysis and see the top 5 stocks in this list, click 5...
CONMED Corporation (NYSE:CNMD) Q1 2024 Earnings Call Transcript
Operator: Thank you for standing by and welcome to CONMED’s First Quarter Fiscal Year 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Should You Invest in CONMED (CNMD)?
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” first quarter 2024 investor letter. A copy of the letter can be downloaded here.
11 Best Beaten Down Dividend Stocks to Invest in Now
In this article, we discuss 11 best beaten down dividend stocks to invest in.
12 52-Week Low Dividend Stocks To Consider
In this article, we discuss 12 52-week low dividend stocks to consider.
CONMED Corporation (NYSE:CNMD) Q4 2023 Earnings Call Transcript
CONMED Corporation misses on earnings expectations. Reported EPS is $1.06 EPS, expectations were $1.11.
CONMED Corporation (NYSE:CNMD) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by. And welcome to CONMED’s Q3 Fiscal Year 2023 Earnings Call. At this time all participants are in a listen-only mode.
CONMED Corporation (NYSE:CNMD) Q2 2023 Earnings Call Transcript
Operator: Before the conference call begins, let me remind you that during this call, management will be making comments and statements regarding its financial outlook, its plans and objectives.